MedTrace Logo

Alzheimer Prevention Trials (APT) Webstudy

NCT03638583 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2025-07-16

No results posted yet for this study

Summary

The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.

Conditions

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Brigham and Women's Hospital

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Paul Aisen, MD · USC ATRI

  • Reisa Sperling, MD · Brigham and Women's Hospital

  • Jeffrey Cummings, MD · The Cleveland Clinic

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03638583 on ClinicalTrials.gov